Dataversity

JUNE 10, 2022

More data is being collected and analyzed than ever before in both clinical and research settings. But as pharmaceutical and health care companies begin to apply AI and machine learning to these, they need considerable computing power (“compute”) and storage. Often, they […].

Pharmaceutical 130

Pharmaceutical Data Architecture 130

The Data Administration Newsletter

DECEMBER 6, 2022

The FAIR principles for data sets are gaining traction, especially in the pharmaceutical industry in Europe. In a world of exponential data growth and ever-increasing silo-ization, the FAIR principles are needed more than ever. FAIR stands for: Findable, Accessible, Interoperable and Reusable.

Pharmaceutical 52

Pharmaceutical Data Architecture Data Management 52

The Data Administration Newsletter

FEBRUARY 2, 2021

The example of the myriad of COVID-19 challenges shows that coordinated, data-driven action across boundaries has helped fast-track solutions such as testing, vaccines, and non-pharmaceutical interventions. In this article, we will explore how organizations can […].

Pharmaceutical 52

Pharmaceutical Innovation Data Governance Data Architecture 52

Domo

SEPTEMBER 11, 2019

When they did, we had the opportunity to talk about how Domo is designed to meet the enterprise security, compliance, and privacy requirements of our customers, particularly in highly regulated industries such as financial services, government, healthcare, pharmaceuticals, energy and technology.

Data Warehouse 52

Data Warehouse Pharmaceutical Healthcare Real-time Data 52

Dataversity

JANUARY 2, 2025

Connected intelligence (CI) and end-to-end quality are two concepts that, when combined, have a transformative impact on the future of drug development and clinical trials,marking asignificant changein how pharmaceutical companies manage the process of bringing new products to market.

Pharmaceutical 147

Pharmaceutical Data Quality Data Governance Data Architecture 147